Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ondansetron Hikma 4mg°


Not recommended

Not recommended
Ondansetron Hikma 4mg° :
Type Medicine Withdrawn
Originator Zofran Ampoules 4mg
Agent Hikma-Liban
Distributor Hikma-Liban
Laboratory Hikma Pharmaceuticals
Manufacturer Hikma Pharmaceuticals PLC
Manufacturing Type G
Origin Jordan
ATC A04AA01

Your comment will appear shortly after approval

Ondansetron Hikma 4mg° :

Revision Date : 30/01/2017


Effect Frequency
Anaphylaxis Rare
Arrhythmia Uncommon
Blindness transient (Temporary vision loss) Very rare
Bradycardia Uncommon
Chest pain Uncommon
Constipation Common
Dizziness Rare
Dyskinesia Uncommon
Dystonic reaction Uncommon
ECG ST segment depression Uncommon
Extrapyramidal symptoms Uncommon
Flushing Common
Headache Very Common
Hiccups Uncommon
Hypotension Uncommon
Immediate hypersensitivity reaction Rare
Liver function test abnormal Uncommon
Movement disorder Uncommon
Oculogyric crisis Uncommon
QT interval prolonged (QT prolongation) Rare
Seizures Uncommon
Sensation of heat (Feeling of warmth) (Sensation of warmth) Common
ST segment elevation myocardial infarction Uncommon
Torsade de pointes Rare
Vision blurred Rare
Visual impairment Rare

Different Units By MoH Code

Revision Date : 01/06/2008

Ondansetron Hikma 4mg°  MoH 5777 :
Form Solution for injection
Packaging Ampoules
Package Size 5x2ml
Strength 4mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 218033/09
Submission date 01/01/2009
Registration Year 2010
Withdrawn Date 2017


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info